All Releases
 |
Bioheart, Inc. Announces Additional Funding Support
Aug 21, 2008
|
18.0 KB |
|
| |
SUNRISE, Fla., Aug 21, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc., (Nasdaq: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, today announced receipt of a $1 million unsecured loan from Rogers Telecommunications Limite...
|
|
Bioheart, Inc. to Present at Red Chip Investor Conference in New York
Aug 1, 2008
|
15.2 KB |
|
| |
SUNRISE, Fla., Aug 01, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc. (Nasdaq: BHRT) today announced that Howard J. Leonhardt, Chairman and CEO of Bioheart, will present a corporate overview Thursday, August 21, 2008 at 9:30 a.m. ET during the Red Chip Investor Conference at the Marriott Marquis in New York. A live audio webc...
|
|
Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.
Aug 1, 2008
|
19.6 KB |
|
| |
SUNRISE, Fla., Aug 01, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc., (Nasdaq: BHRT), announced it has entered into a non-binding letter of intent to acquire MEDICALGORITHMICS, Ltd. and the worldwide rights to the POCKETECG, a real-time wireless beat-to-beat, intelligent heart monitor and diagnostic system, designed for long...
|
|
Bioheart, Inc. Announces Results of Annual Meeting
Jul 30, 2008
|
19.3 KB |
|
| |
SUNRISE, Fla., July 30, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc., (Nasdaq: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, announced the adoption of the following resolutions during today's Annual Shareholders Meet...
|
|
Bioheart, Inc. Announces Financial Results for Second Quarter 2008
Jul 30, 2008
|
22.8 KB |
|
| |
SUNRISE, Fla., July 30, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc., (Nasdaq: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, today announced financial results for the second quarter ended June 30, 2008.
Recent Cl...
|
|
Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
Jul 24, 2008
|
21.8 KB |
|
| |
SUNRISE, Fla., July 24, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Results of a preclinical study involving the injection of myoblasts modified to express stromal derived factor-1(alpha) protein (SDF-1) into the scar tissue of the myocardium of rats, which suggest improved heart function, were recently presented at two scientific meetin...
|
|
Bioheart, Inc., Announces Management Change
Jul 11, 2008
|
17.2 KB |
|
| |
SUNRISE, Fla., July 11, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc., (Nasdaq: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, announced today that Doug Owens, Director, Clinical Affairs, will assume responsibility for...
|
|
Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
Jul 10, 2008
|
19.7 KB |
|
| |
SUNRISE, Fla., July 10, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc. (Nasdaq: BHRT), a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases, today announced it has secured worldwide non-exclusive distribution rights to the Bioheart ...
|
|
Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer
Jul 3, 2008
|
17.0 KB |
|
| |
SUNRISE, Fla., July 3, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc., (Nasdaq: BHRT) a biotechnology company that is focused on the development of autologous (patient-derived) cell therapies and devices for the treatment of chronic and acute heart damage, today announced that its Board of Directors appointed Howard J. Leonha...
|
|
Bioheart, Inc., Added to Russell Microcap Index
Jul 2, 2008
|
15.9 KB |
|
| |
SUNRISE, Fla., July 2, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc. (Nasdaq: BHRT) a biotechnology company that is focused on the development of autologous (patient-derived) cell therapies and devices for the treatment of chronic and acute heart damage, today announced it has been added to the Russell Microcap Index after t...
|
|
Bioheart, Inc. to Transfer to Nasdaq Capital Market
Jun 10, 2008
|
13.9 KB |
|
| |
SUNRISE, Fla., June 10, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc. (Nasdaq: BHRT) today announced that it has received approval to transfer the listing of its common stock to the Nasdaq Capital Market. The Company's common stock will be transferred from The Nasdaq Global Market to The Nasdaq Capital Market at the opening ...
|
|
Bioheart, Inc. to Host Annual Meeting of Shareholders on Wednesday, July 30, 2008
Jun 6, 2008
|
15.4 KB |
|
| |
SUNRISE, Fla., June 6, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc. (Nasdaq: BHRT) will host its 2008 Annual Meeting of Shareholders on Wednesday, July 30, 2008 at Chispa Restaurant, located at 11500 NW 41st Street in Doral, Florida. The meeting will commence at 9:00 am EASTERN.
Interested parties may listen to the Bioh...
|
|
Bioheart, Inc. Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements
May 23, 2008
|
14.8 KB |
|
| |
SUNRISE, Fla., May 23, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc. (Nasdaq: BHRT) announced that on May 21, 2008 it received a letter from the Nasdaq Stock Market (the "Nasdaq Letter") advising that, for the last 10 consecutive trading days, the Company's market value of listed securities had been below the minimum $50,000...
|
|
Bioheart, Inc. Announces Financial Results for First Quarter 2008
May 15, 2008
|
22.2 KB |
|
| |
SUNRISE, Fla., May 15, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc. (Nasdaq: BHRT) a biotechnology company that is focused on the development of autologous (patient-derived) cell therapies and devices for the treatment of chronic and acute heart damage, today announced financial results for the quarter ended March 31, 2008....
|
|
Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
Apr 1, 2008
|
21.3 KB |
|
| |
CHICAGO, April 1, 2008, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc. (Nasdaq: BHRT) announced today that final six-month, follow-up patient data was presented today during the late-breaking clinical trial sessions at the American College of Cardiology, suggesting that MyoCell(R) myoblast clinical cell therapy is a safe and ...
|
|
Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
Apr 1, 2008
|
19.3 KB |
|
| |
CHICAGO, April 1, 2008, 2008 /PRNewswire via COMTEX News Network/ -- Final six-month, follow-up patient data presented today during the late-breaking clinical trial sessions at the American College of Cardiology, suggest MyoCell(R) myoblast clinical cell therapy is a safe and potentially effective alternative treatment to standard medical therapy a...
|
|
Bioheart, Inc. Announces Financial Results for Full-Year 2007
Mar 27, 2008
|
22.8 KB |
|
| |
SUNRISE, Fla., March 27, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc. (Nasdaq: BHRT) today announced financial results for the year ended December 31, 2007.
Revenues for the year were $313,000 compared to $106,000 in 2006. Research and development expenses for 2007 were $11.3 million compared to $6.9 million in 2006; an...
|
|
Bioheart, Inc. to Report Full Year 2007 Financial Results on Thursday, March 27, 2008
Mar 20, 2008
|
15.2 KB |
|
| |
SUNRISE, Fla., March 20, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc. (Nasdaq: BHRT) will report financial results for the year ended December 31, 2007 after the close of the market on Thursday, March 27, 2008. The Company has scheduled a conference call for Thursday, March 27, 2008 at 4:30 p.m. Eastern to discuss these res...
|
|
Bioheart Awarded Patent for Method to Repair Heart Tissue by Combination of Cell-Based Therapy and Electrostimulation
Mar 17, 2008
|
17.8 KB |
|
| |
SUNRISE, Fla., March 17, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc. (Nasdaq: BHRT) a biotechnology company that is focused on the development of autologous (patient-derived) cell therapies and devices for the treatment of chronic and acute heart damage, today announced that it has been awarded U.S. Patent #: 7341062 (J. C...
|
|
Bioheart Founder, Howard J. Leonhardt, Becomes Chairman of the Board of Directors
Mar 17, 2008
|
17.3 KB |
|
| |
SUNRISE, Fla., March 17, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Bioheart, Inc. (Nasdaq: BHRT), a biotechnology company that is seeking to develop autologous (patient-derived) cell therapies and devices for the treatment of chronic and acute heart damage, today announced that company founder Howard J. Leonhardt will, effective immedi...
|
|
|
= add release to Briefcase
|
0.70
Web
site by Bromley Printing and Design
